{
    "eid": "2-s2.0-85105018855",
    "title": "Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial",
    "cover-date": "2021-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Isabelle Andrieux-Meyer",
        "Soek Siam Tan",
        "Sombat Thanprasertsuk",
        "Nicolas Salvadori",
        "Caroline Men\u00e9trey",
        "Fran\u00e7ois Simon",
        "Tim R. Cressey",
        "Hajjah Rosaida Hj Mohd Said",
        "Muhammad Radzi Abu Hassan",
        "Haniza Omar",
        "Hoi Poh Tee",
        "Wah Kheong Chan",
        "Suresh Kumar",
        "Satawat Thongsawat",
        "Kanawee Thetket",
        "Anchalee Avihingsanon",
        "Suparat Khemnark",
        "Sabine Yerly",
        "Nicole Ngo-Giang-Huong",
        "Sasikala Siva",
        "Alistair Swanson",
        "Vishal Goyal",
        "Francois Bompart",
        "Bernard P\u00e9coul",
        "Shahnaz Murad"
    ],
    "citedby-count": 10,
    "ref-count": 30,
    "ref-list": [
        "HCV Factsheet",
        "Global health sector strategy on viral hepatitis 2016-2021",
        "Progress towards hepatitis C virus elimination in high-income countries: an updated analysis",
        "Endgame: Egypt's path to eliminating hepatitis B and C",
        "Global report on access to hepatitis C treatment. Focus on overcoming barriers",
        "Disparity in market prices for hepatitis C virus direct-acting drugs",
        "Chronic hepatitis C treatment expansion factsheet",
        "Daclatasvir update",
        "Glecaprevir/pibrentasvir (G/P) update",
        "Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission",
        "Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study",
        "Prediction of cirrhosis in patients with chronic hepatitis c by genotype 3",
        "Treatment guidlines treatment-naive genotype 3 with compensated cirrhosis",
        "EASL recommendations on treatment of hepatitis c 2018",
        "Ravidasvir + sofosbuvir",
        "An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacy",
        "A new potent NS5A inhibitor in the management of hepatitis c virus: ravidasvir",
        "Effectiveness of ravidasvir plus sofosbuvir in interferon-na\u00efve and treated patients with chronic hepatitis C genotype-4",
        "Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: a phase 2 study",
        "Efficacy and safety of all-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin in treatment-na\u00efve noncirrhotic HCV genotype 1 patients: results from a phase 2/3 clinical trial in China",
        "Use of ribavirin for hepatitis C treatment in the modern direct-acting antiviral era",
        "Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03)",
        "Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme",
        "All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study",
        "Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections - a Scandinavian real-life study",
        "Overview of new treatments for hepatitis C virus: moving towards a public health agenda",
        "Sofosbuvir and velpatasvir for HCV Genotype 2 and 3 infection",
        "Sofosbuvir\u2013velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial",
        "Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis c in the era of new oral direct-acting antivirals: a concise review",
        "Real-world efficacy of daclatasvir and sofosbuvir, with and without ribavirin, in HIV/HCV coinfected patients with advanced liver disease in a French early access cohort"
    ],
    "affiliation": [
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60091478",
            "affilname": "Institute of research for development, Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60091478",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sungai Buloh",
            "@id": "60090633",
            "affilname": "Hospital Sungai Buloh",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090633",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60031637",
            "affilname": "Nakornping Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031637",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60029157",
            "affilname": "Universiti Malaya",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Putrajaya",
            "@id": "60012747",
            "affilname": "Kementerian Kesihatan Malaysia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012747",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Geneva",
            "@id": "60009963",
            "affilname": "H\u00f4pitaux Universitaires de Gen\u00e8ve",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009963",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ampang Jaya",
            "@id": "126235792",
            "affilname": "Ampang Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126235792",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "126136566",
            "affilname": "Drugs for Neglected Diseases initiative",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126136566",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Geneva",
            "@id": "124518998",
            "affilname": "Drugs for Neglected Diseases Initiative",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124518998",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "New York",
            "@id": "116847078",
            "affilname": "Drugs for Neglected Diseases initiative",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116847078",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "106545448",
            "affilname": "Bamrasnaradura Infectious Diseases Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106545448",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Alor Setar",
            "@id": "106383710",
            "affilname": "Hospital Sultanah Bahiyah",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106383710",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Kuantan",
            "@id": "106383658",
            "affilname": "Hospital Tengku Ampuan Afzan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106383658",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Batu Caves",
            "@id": "101767170",
            "affilname": "Hospital Selayang",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101767170",
            "affiliation-country": "Malaysia"
        }
    ],
    "funding": [
        "Data Safety and Monitoring Board",
        "European Egyptian Pharmaceutical industries, Alexandria, Egypt",
        "Foundation for Art",
        "Microbiology Unit of the Pathology Department, Hospital Kuala Lumpur, Malaysia",
        "Pierre Mendiharat",
        "Starr International Foundation",
        "NIH",
        "M\u00e9decins Sans Fronti\u00e8res",
        "Swiss Agency for Development and Cooperation",
        "Eunice Kennedy Shriver National Institute of Child Health and Human Development",
        "Ministry of Science and Technology",
        "National Science and Technology Development Agency",
        "Ministry of Science and Technology",
        "Ministry of Health, Malaysia",
        "DNDi"
    ]
}